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Objectives. The purpose of this pilot study was to determine 
whether leukocyte activation occurs, whether ieukocyte-platelet 
complexes develop and whether there is any association between 
these findings and clinical outcome after coronary angioplasty. 
Background. Increased expression of CDllb on monocytes and 
neutrophils promotes their adhesion to endothelial cells, extracel- 
lular matrix and smooth muscle cells. Thrombin.activated plate- 
lets adhere to monocytes and neutrophils through P-selectin. 
These cell complexes may affect the inflammatory process and, 
thus, the outcome of coronary angioplasty. 
Methods. During elective single-vessel coronary angioplasty in 
11 men, samples were obtained for flow cytometric detection of 
CDllb, as well as the percent of leukocytes with adherent platelets 
and the intensity of bound platelet fluorescence (number of 
platelets/leukocyte). 
Results. After angioplasty, there was an increase in CDllb 
(monocytes: p = 0.001, neutrophils: p = 0.02) and leukocytes with 
adherent platelets (p = 0.02). During follow-up, five patients 
remained in stable condition and six had subsequent clinical 
events: restenosis and progression of disease requiring coronary 
artery bypass grafting (n = 3), myocardial infarction involving the 
dilated artery (n = 1) and unstable angina (n = 2). Values for 
leukocyte CDllb expression, the percent of leukocytes with ad- 
herent platelets and the intensity of bound platelet fluorescence 
were higher both before and after angioplasty in the six patients 
experiencing clinical events. 
Conclusions. Despite standard aspirin and heparin therapy, 
leukocyte activation with platelet adherence occurs after coronary 
angioplasty. The magnitude of leukocyte activation and platelet 
adherence appears to be higher in patients experiencing late 
clinical events. 
(J Am Coil Cardiol 1996;28:345-53) 
A basic role for cell adhesion molecules has been suggested in
the pathogenesis of atherosclerosis (1-5), acute coronary syn- 
dromes (6,7), reperfusion injury (8-12) and allografl arteri- 
opathy (13). Neutrophil activation after coronary angioplasty 
has been previously reported (14) on the basis of increased 
plasma elastase l vels and decreased ex vivo release of reactive 
oxygen species (superoxide anion). Increased expression of 
CDllb on neutrophils has been detected in blood from the 
coronary sinus collected immediately after elective coronary 
angioplasty (15). 
CDllb/CD18 (Mac-l) is a heterodimer in the beta 2integrin 
family that promotes adhesion of neutrophils and monocytes 
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to endothelial cells, extracellular matrix, iC3b and components 
of the coagulation cascade (e.g., Factor X and fibrinogen). It is 
stored in secretory granules in these leukocytes and can be 
rapidly mobilized to the cell surface after cell activation. On 
circulating leukocytes, constitutive surface levels of CD1 l b are 
relatively low with -50,000 binding sites/cell (16). Activation 
of neutrophils, for example, may increase surface levels of 
Mac-1 four- to fivefold. Flow cytometric determination of
leukocyte surface levels of CDllb has been used as an index of 
intravascular ctivation of these cells. 
Platelet adhesion and aggregation also play a significant 
role in acute coronary syndromes (17-21). yon Willebrand 
factor binding to platelet membrane glycoprotein Ib (22) and 
fibrinogen or von Willebrand factor binding to platelet mem- 
brane glycoprotein IIb/IIIa initiate platelet functional re- 
sponses (23). Thrombin-activated platelets adhere to mono- 
cytes and neutrophils through P-selectin (24,25). Markers of 
thrombin generation and activity have been detected in pa- 
tients undergoing coronary angioplasty (26). The detection of 
activated platelets in clinical disorders (23) and the dynamics 
of leukocyte-platelet interactions in whole blood during pro- 
cedures uch as coronary artery bypass grafting or cardiopul- 
monary bypass in congenital heart disease have recently been 
described (27-30). Leukocyte-platelet complexes probably par- 
ticipate in the vascular inflammatory process after coronary 
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angioplasty. The purpose of this pilot study was to determine 
whether, during elective single-vessel angioplasty, 1) monocyte 
and neutrophil activation occurs, 2) leukocyte-platelet com- 
plexes develop, and 3) there is an association between these 
findings and clinical outcome. 
Methods 
Patients. The study group consisted of 11 men undergoing 
elective single-vessel coronary angioplasty. All of the patients 
were in stable condition, having presented tothe hospital with 
progressive angina but no evidence of acute myocardial infarc- 
tion. All medications (including aspirin, nitrates and calcium 
channel or beta-adrenergic blocking agents) were continued 
throughout the hospital stay and the 6-month follow-up period. 
Baseline blood studies obtained before the procedure included 
complete blood count and differential, platelet count, pro- 
thrombin/activated partial thromboplastin me, chemistry pro- 
files, collagen vascular studies, human immunodeficiency virus 
testing, rapid plasma reagin test, hepatitis profile and lipopro- 
tein profile. Each elective angioplasty was started at 11:00 AM, 
when the first cardiothoracic procedure was near completion 
and an operating room was available. The study patients were 
always the first angioplasty case of the day and only one study 
patient was enrolled on any particular day. This study was 
approved by the Institutional Review Boards of Baylor College 
of Medicine and the Houston Veterans Administration Med- 
ical Center; all patients gave written informed consent. 
Protocol. After local anesthesia (2% lidocaine, 20 ml), a 7F 
sheath was placed in the femoral vein and an 8F or 10F sheath 
was placed in the femoral artery. After the initial 3 ml aspirate 
was discarded, blood was collected into sterile 3-ml plastic 
syringes from the venous heath, the coronary guiding catheter 
and a pigtail catheter were placed in the right atrium at the 
ostium of the coronary sinus. In preliminary studies, blood 
samples were collected by using sterile preservative-containing 
or preservative-free heparin or sodium citrate before and after 
systemic administration f 15,000 U of heparin and before and 
after injection of contrast material iopamidol (lsovue-370, 
Squibb Diagnostics). In each patient, the various conditions 
did not significantly change flow cytometry esults at the three 
collection sites (31,32). For the present study, samples were 
collected into sterile plastic syringes by using sterile 
preservative-containing heparin after systemic administration 
of heparin. The preprocedure sample was obtained before 
administration of contrast material and the postprocedure 
sample after administration f contrast material (33). 
Fluorescence labeling. For platelet-leukocyte s udies, the 
anticoagulated whole blood was immediately placed in an 
equal volume of 2.5% paraformaldehyde at room temperature 
for 5 rain and then placed on ice. After 1 h, Tris-glycine 
solution, 1:8 vol/vol (250 mmol/liter Tris and 500 mmol/liter 
glycine), was added (to stop fixation). Samples were kept on ice 
until the day's study was completed (<3 h). Samples were 
washed three times in Tyrode's-HEPES buffer (HEPES 5 
retool/liter, sodium chloride; 140 retool/liter; potassium chlo- 
ride 2.7 mmol/liter; dextrose 5.5 mmol/liter; sodium phosphate 
monobasic 0.42 mmol/liter; and sodium bicarbonate 12 mmol/ 
liter, pH 7.4) with 2 mg/ml of bovine serum albumin (TH- 
BSA). For leukocyte studies, the anticoagulated whole blood 
was placed immediately on ice without fixation. 
Monoclonal antibodies were commercially available, puri- 
fied whole immunoglobulins. All experiments included isotype- 
specific irrelevant monoclonal antibodies as controls. The 
following antibodies were used for platelet-leukocyte s udies: 
anti-CD41a (phycoerythrin conjugated [PE]) recognizes IIIa of 
platelet glycoprotein IIb/IIIa (AMAC, Inc.), anti-CD45R0 
[fluorescein isothiocyanate conjugated (FITC)] recognizes a
CD45 isoform present on neutrophils, monocytes and lympho- 
cytes but neither erythrocytes nor platelets (DAKOpatts, Den- 
mark), and anti-CD14 (FITC) recognizes Mo2 present on 
monocytes (Becton Dickinson Immunocytometry S stems). 
For leukocyte activation studies, anti-L-selectin (FITC) and 
anti-CDllb (PE) were used (Becton Dickinson Immunocy- 
tometry Systems). 
For leukocyte-platelet studies, 100/sl of the fixed washed 
cells (106 leukocytes/ml) was incubated with saturating concen- 
trations of the antibodies (anti-CD41a [PE] and anti-CD45R0 
[FITC], anti-IGg~ control [PE] and anti-CD45R0 [FITC], 
anti-CD41a [PE] and anti-CD14 [FITC], anti-IGg 1 control 
[PE] and anti-CD14 [FITC]). For the leukocyte activation 
studies, 100/xl of anticoagulated whole blood was incubated 
with saturating concentrations of the antibodies (anti-L- 
selectin [FITC] and anti-CDllb [PE], anti-IGg2~ ~ control [PE] 
and anti-IGgz~ control [FITC]). After a 20-rain incubation in 
the dark at 4°C, cells were washed twice (Tyrode's-HEPES 
buffer), resuspended in 1 ml of lysing reagent (Becton Dickin- 
son Immunocytometry Systems), mixed and incubated in the 
dark for 10 rain at 4°C. The cells were then washed (TH-BSA), 
resuspended in 200/xl of 1% paraformaldehyde and stored in 
the dark at 4°C in 5 ml of polypropylene snap cap tubes until 
they could be read (<3 days). 
Flow eytometry. Samples were analyzed on a FACScan 
flow cytometer (Becton Dickinson Immunocytometry S s- 
tems). Our laboratory iscertified and approved by the College 
of American Pathologists; thus, routine daily procedures in- 
clude standard reference sampling with Calibrite and setting 
live gates with standardized antibodies (Becton Dickinson 
Immunocytometry Systems). The antibodies that bind to leu- 
kocytes were titered by using flow cytometry to determine the 
concentration that saturated surface binding sites of stimulated 
cells [i.e., stimulation with 10 nmol/liter fMLP (Sigma Chem- 
ical Co.), 37°C, 15 min]. Antibodies were used at twice the 
saturating concentration to avoid antibody depletion. For 
leukocyte-platelet studies, live gating was performed on 
leukocyte-sized vents (either neutrophils based on the anti- 
CD45R0 FITC-labeled population or monocytes based on the 
anti-CD14 FITC-labeled population). Ten thousand events 
were measured for neutrophils and 5,000 events for mono- 
cytes. Both the percent of leukocytes with positive platelet 
fluorescence (PE) and the mean platelet marker fluorescence 
intensity of the leukocytes were measured. Measurements of 
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Table 1. Baseline Characteristics of the 11 Male Study Patients 
LAD RCA PTCA DCA 
Age (yr) 63 _+ 4 54 _+ 4 
PTCA 2 4 
DCA 3 2 
No. of lesions 1.2 + 0.2 1.7 + 0.2 1.7 -- 0.2 1.2 _+ 0.2 
Max % stenosis 85 _+ 4.2 93 +_ 1.7 89 _+ 3 89 _+ 3 
Final % stenosis 28 _+ 6 23 _+ 3 27 _+ 6 23 _+ 3 
Max atmospheres 8.4 _+ 1 10.7 + 1.5 10.3 _+ 1.4 8.8 _+ 1.4 
Inflation duration (s) 379 _+ 78 635 + 149 668 _+ 130 339 _+ 92 
No. of inflations 3.4 _+ 1 6.7 _+ 2 6.8 + 1.5 3.2 -- 0.9 
Outcome 
CABG 1 2 2 1 
Chest pain 1 2 3 0 
Stable 3 2 1 4 
Unless otherwise indicated, data are presented as mean value -- SEM or 
number of patients. CABG = coronary artery bypass grafting; DCA = direc- 
tional coronary atherectomy; LAD = left anterior descending coronary artery; 
PTCA = percutaneous transluminal coronary angioplasty; RCA = fight coro- 
nary artery. 
leukocyte surface CDl lb  and L-selectin were done by live 
gating on leukocyte-sized events, with the use of forward- 
scatter versus side scatter variables to distinguish neutrophils 
from monocytes. Ten thousand events were measured for 
neutrophils and 5,000 events were measured for monocytes. 
Statistical analysis. Data are presented as mean value _+ 
SEM when applicable. Comparisons among sampling sites 
were made by analysis of variance and a Newman-Keuls 
multiple comparison test was used to determine which means 
were significantly different. Comparisons were made 1) before 
and after coronary angioplasty, and 2) on the basis of outcome 
(stable condition versus chest pain events) for each measured 
variable by grouping all sites with the use of nonparametric 
analysis. Linear regression analysis of the measurements of
leukocyte surface CD 1 lb and L-selectin expression was used 1) 
to compare results for each patient before and after the 
procedure on either monocytes or neutrophils, and 2) to 
compare the percent change on monocytes to the percent 
change on neutrophils for each patient. Stepwise multiple 
linear regression analyses were used to compare leukocyte- 
platelet complex fluorescence intensities and the percent of the 
population in each intensity range to the leukocyte surface 
CDl lb  expression on either monocytes or neutrophils. A p 
value -< 0.05 was considered significant. 
Results 
Patients. The 11 patients had a mean age _+ SEM of 58.3 _+ 
3.1 years (range 41 to 76). No patient had evidence of renal, 
liver, rheumatic or infectious disease. Four men were Afro- 
American and seven were white. Nine men had hypertension, 
five smoked and four had diabetes. Four men were taking 
lipid-lowering agents. Two men had recent (> 14 and <30 days, 
respectively) inferior myocardial infarction and three had 
previous coronary angioplasty with restenosis (of the right 
coronary artery in two and of the left anterior descending 
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Figure 1. Flow cytometric histograms of CDllb expression. Repre- 
sentative histograms from the coronary artery guiding catheter blood 
sample taken before (solid line) and after (dotted line) coronary 
angioplasty show that CD1 lb expression i creased on both monocytes 
and neutrophils, x axis = number of events, y axis = log of fluores- 
cence (FL2) for phycoerythrin. MAC-1 = CDllb. 
coronary artery in one). Seven patients had single-vessel 
disease and four had double-vessel disease. Ejection fraction 
ranged from 25% to 60% (mean 51 _+ 4%). Baseline patient 
characteristics related to the artery dilated (left anterior de- 
scending or right coronary artery) showed only one difference: 
Platelet counts were higher in patients with right coronary 
artery disease (204 _+ 10 x 103 vs. 267 _+ 14 x 103, p = 0.005). 
With respect o the type of procedure (percutaneous translu- 
minal coronary angioplasty or directional atherectomy), ex- 
pected differences in the duration and the number of balloon 
inflations were documented (Table 1). Procedures were all 
successful and uncomplicated. Lipid profiles showed mild 
hyperlipidemia with elevated low density lipoprotein (LDL) 
and diminished high density lipoprotein (HDL) concentrations 
(total cholesterol 227 _+ 15, LDL 148 _+ 8 and HDL 36 _+ 2 
rag/all). Leukocyte and platelet profiles were within normal 
ranges (total white blood cell count 6.7 _+ 0.4 x 103, neutro- 
phils 58 _+ 2%, lymphocytes 28 _+ 2%, monocytes 8 _+ 1%). 
Flow cytometry. Representative histograms from the coro- 
nary artery guiding catheter blood sample taken before and 
after coronary angioplasty show increased CDl lb  expression 
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Figure 2. Flow cytometric histograms ofplatelet fluorescence intensity 
on leukocytes. Representative histograms from the coronary artery 
guiding catheter blood sample show three peaks (low, high and very 
high) of platelet fluorescence intensity on monocytes and neutrophils. 
Before angioplasty (solid line), most leukocytes had few adherent 
platelets and, thus, a dominant low peak. The intensity of bound 
platelet fluorescence (i.e., the number of platelets/leukocyte) increased 
after the procedure (dotted line) on both monocytes and neutrophils. 
x axis = number of events, y axis = log of fluorescence (FL2) for 
phycoerythrin. 
on both monocytes and neutrophils (Fig. 1). Cytometric histo- 
grams howed three peaks (arbitrarily called low, high and very 
high) of platelet fluorescence intensity on both monocytes and 
neutrophils (Fig. 2). Before angioplasty, most leukocytes had 
few adherent platelets, thus a dominant low peak. The inten- 
sity of bound platelet fluorescence (i.e., the number of plate- 
lets/leukocyte) increased after the procedure on both mono- 
cytes and neutrophils. 
Leukocyte activation. CDllb expression on monocytes 
(p = 0.001) and neutrophils (p = 0.02 [Fig. 3]) increased after 
angioplasty. For each patient, comparison of monocyte (r = 
0.93, p < 0.0001) and neutrophil (r = 0.91, p < 0.0001) CDllb 
expression before and after angioplasty revealed a correlation 
of expression. Comparison of the percent change in monocyte 
expression with percent change in neutrophil expression of 
CDllb revealed that both cell types were affected similarly by 
the procedure (r = 0.70, p < 0.0001). For each patient, paired 
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Figure 3. Leukocyte CDllb expression. Flow cytometric analysis of 
blood samples from all three sites revealed a significant increase in 
CDllb expression (fluorescence intensity) on monocytes (*p = 0.001) 
and neutrophils ('tp = 0.02) after angioplasty (Post-PTCA). These box 
plots show five percentiles. The top of the box represents he 75th 
percentile, the bottom the 25th percentile; the middle 50% is con- 
tained within the span of the box boundaries, the line inside the box 
represents the median, the lines extending above and below the box are 
whiskers to the 90th and the 10th percentile, respectively. Numbers 
inside the box represent the mean value -+ SEM. 
data before and after angioplasty at each sample site display a 
general trend toward increased CDllb expression on mono- 
cytes and neutrophils (Fig. 4). 
A change in L-selectin expression on leukocytes could not 
be detected after the procedure at any one site or when all sites 
were combined (monocytes 117 + 13 to 123 + 14 or neutro- 
phils 109 + 13 to 128 _+ 17 fluorescence intensity). Paired data 
before and after angioplasty from all sample sites combined, 
but not individual sample sites, show an increased L-selectin 
expression only on neutrophils (p = 0.0125). For each patient, 
comparison of L-selectin expression before and after angio- 
plasty revealed the following correlations: monocytes r = 0.86, 
p = 0.0001; neutrophils r = 0.94, p = 0.0001. However, 
comparison of the change in monocyte xpression with the 
change in neutrophil expression revealed little similarity (r = 
0.48, p = 0.04). 
Leukocyte-platelet interactions. Both the mean platelet 
fluorescence intensity of the leukocytes (i.e., the number of 
platelets/leukocyte) and the percent of leukocytes with highly 
positive platelet fluorescence increased after angioplasty when 
all sites were combined: monocytes 497 + 165 to 769 + 211 
fluorescence intensity (2 + 1% to 11 _+ 3%) or neutrophils 
230 _+ 100 to 730 _+ 217 fluorescence intensity (0.2 _+ 0.1% to 
3 ~ 1%). The venous sheath samples did not have as many 
circulating leukocyte-platelet complexes. However, statistically 
similar results were found when the data were analyzed with 
just the two sample sites closest o the procedure (coronary 
artery guiding catheter and the coronary sinus pigtail catheter 
[Fig. 5]). A stepwise multiple linear regression analysis of the 
measurements of leukocyte-platelet complex fluorescence in- 
tensities and the percent of the population in each intensity 
range correlated with the surface CD1 lb expression on mono- 
cytes (p = 0.004) or neutrophils (p : 0.0025). 
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Figure 4. Leukocyte CDllb expression at each sampling site. For each 
of the 11 patients, paired data for each sample site show a general 
trend toward greater CDllb expression (fluorescence intensity) on 
monocytes (A) and neutrophils (B) after (Post) than before (Pre) 
angioplasty. Circles = mean values _+ SEM. 
Clinical outcome. Five patients were without recurrent 
symptoms and showed no restenosis on cardiac catheterization 
at 4 to 6 months (mean 5 _+ 0.7). Six patients had chest pain 
events: restenosis and progression of disease requiring coro- 
nary artery bypass grafting (n -- 3), myocardial infarction 
involving the dilated artery (n = 1) and unstable angina (n = 
2). No demographic or procedural differences between the two 
patient groups were detected (Table 2). Leukocyte CDllb 
expression was greater both before and after angioplasty in the 
six patients experiencing clinical events (Fig. 6). L-selectin 
expression on leukocytes was higher both before and after 
angioplasty in the six patients experiencing clinical events 
(patients without events [stable group]: monocytes 57 _+ 6 to 
69 _+ 8, neutrophils 56 _ 6 to 53 _+ 6; patients with a clinical 
event [chest pain group]: monocytes 167 _+ 14 to 173 + 17, 
neutrophils 153 _ 17 to 190 _+ 23, p = 0.0001). When the two 
patient groups were compared, the percent change in L-selectin 
expression was significant only for neutrophils (stable group -3  _+ 
7% vs. chest pain group 21 _+ 8%, p < 0.05)• Both the mean 
platelet marker fluorescence intensity of the leukocytes (i.e., the 
[]ere rn'CA 
• Post PTCA 
Ii 
o 
Percent ofneutrophils 90-kl 85+9 * 95:1 12.+.2 0.2.~0.2 3:1:1" 
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Figure 5. Transcardiac leukocyte-platelet interactions. The mean 
platelet fluorescence intensity (the number of platelets/leukocyte) is 
presented within the three ranges (low, high and very high intensity) 
where data clustered for all patients studied. The percent of leukocytes 
within each of the three platelet fluorescence intensity ranges is listed 
under the appropriate histogram before (Pre PTCA) and after (Post 
PTCA) angioplasty. From the sample sites closest to the procedure 
(coronary artery guiding catheter and coronary sinus pigtail catheter), 
highly positive platelet fluorescence intensity and the percent of 
leukocytes in this very high intensity group increased after angioplasty 
on both monocytes (*p = 0.02) (A) and neutrophils (*p < 0.05) (B). 
number of platelets/leukocyte) and the percent of leukocytes with 
highly positive platelet fluorescence were greater in the six 
patients experiencing clinical events (Fig. 7). 
D iscuss ion  
The long-term success of percutaneous transluminal coro- 
nary angioplasty has been limited by restenosis (34,35). New 
devices and a variety of pharmacologic strategies have not 
eliminated this problem (36,37). The most promising results to 
date, in >2,000 cases defined as angiographically high risk, 
show reduction in clinical restenosis with the use of monoclo- 
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Table 2. Clinical Outcome of the 11 Study Patients at 5.0 _+ 
0.7 Months 
Outcome Group 
Stable Chest Pain Events 
(n = 5) (n = 6) 
Age (yr) 53 + 4 63 + 4 
LDL cholesterol (mg/dl) 142 + 9 155 _+ 15 
HDL cholesterol (mg/dl) 35 _+ 3 37 -+ 3 
Current smoker 40% 50% 
Diabetes 40% 33% 
Hypertension 80% 83% 
Lesions dilated (no.) 1.4 + 0.2 1.5 _+ 0.2 
Maximal % stenosis 87 _+ 3% 91 _+ 3 
Final % stenosis 21 _+ 2% 28 _+ 5 
Maximal inflation pressure (atm) 8.6 +_ 1.2 10.5 +_ 1.4 
Duration of inflation (s) 410 _+ 161 609 _+ 107 
Inflations (no.) 4.6 _+ 2.2 5.7 _+ 1.0 
PTCA 1 5 
DCA 4 1 
LAD 3 2 
RCA 2 4 
Data presented are mean value +_ SEM or number or percent of patients in 
outcome group. HDL = high density lipoprotein; LDL = low density lipopro- 
tein; other abbreviations a in Table 1, 
nal antibody directed against platelet glycoprotein IIb/IIIa 
complex (38). The pharmacologic strategies have been di- 
rected against various aspects of the restenotic process: plate- 
lets, coagulation cascade, inflammatory cells, smooth muscle 
cell proliferation, vasospasm or hyperlipidemia (39,40). Nu- 
merous potential mediators are involved in each aspect. 
Leukocyte activation-CDllb expression. Results from this 
pilot study suggest hat monocyte and neutrophil activation, 
detected by increased CD1 lb expression, occurs after coronary 
angioplasty. Although Ikeda et al. (15) showed increased 
CDllb expression on coronary sinus neutrophils after angio- 
plasty involving only left coronary artery lesions, we were not 
able to detect this increase. However, our coronary sinus 
samples may reflect echnical errors in the collection of blood 
or positioning of the pigtail catheter when the dilated arteries 
included either ight or left coronary artery lesions. 
In contrast to relatively small changes seen in the postangio- 
plasty samples, analysis of leukocyte variables in our patients with 
subsequent chest pain revealed marked differences in CDllb 
levels on both neutrophils and monocytes. Significant differences 
in leukocyte-platelet complexes were also found in this group, and 
highly significant correlations were found between measures of 
CDllb and platelet adhesion to leukocytes. In a preliminary 
report by Pietersma et al. (41), angiographic evidence of resten- 
osis 6 months after coronary angioplasty could be predicted with 
stepwise multiple linear regression analyses. In preprocedure 
peripheral venous blood samples, stenosis was predicted by 
decreased expression of the neutrophil activation marker CD66 
and increased production by stimulated monocytes of IL-1/3 in 
the setting of left anterior descending artery dilation. 
CD66 functions as a presenter molecule for neutrophil 
sialylated Lewis (x) antigen and participates in neutrophil 
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Figure 6. Clinical outcome and leukocyte CDllb expression. CDllb 
expression (fluorescence intensity) on monocytes was higher both 
before (Pre) and after (Post) angioplasty in patients who had subse- 
quent chest pain events. Within each group (stable In = 5] or chest 
pain [n = 6]), the CDllb expression  monocytes increased after 
angioplasty. Similarly, CDllb expression  neutrophils was higher 
both before and after angioplasty in patients who had subsequent chest 
pain events. Only within the stable group did CDllb expression  
neutrophils increase after angioplasty. These box plots show five 
percentiles: the top of each box represents the 75th percentile, the 
bottom the 25th percentile; the middle 50% is contained within the 
span of the box boundaries, the line inside the box represents the 
median, the lines extending above and below the box are whiskers to 
the 90th and the 10th percentile, respectively. The numbers inside the 
box represent the mean value +_ SEM. 
binding to E-selectin expressed by activated endothelial cells 
(42). CD66 is found in secondary granules along with CDllb 
and both are usually increased when neutrophil activation has 
occurred. It is difficult o envision a low expression of CD66 
without a similarly significant low expression of CDllb (and a 
similar predictive value). However, the method used by Piet- 
ersma et al. (41) to prepare blood samples for flow cytometric 
analysis contains everal steps known to activate leukocytes. 
The centrifugation and separation of buffy coat fractions, 
treatment with ammonium chloride solution and resuspension 
in phosphate-buffered saline solution with 2% fetal calf serum 
all activate neutrophils; that is, they enhance CDllb expres- 
sion and promote L-selectin shedding. Because these steps 
were carried out before fixation in paraformaldehyde, one 
must assume that the level of activation would be similar 
among samples and that it was due to the preparation methods 
and not to the subsequent procedure or its outcome. Thus, it is 
not surprising that flow cytometric analysis of CDlla, CDllb 
and CD1 lc expression on monocytes and neutrophils was not 
predictive of restenosis by univariate regression analysis (41). 
Leukocyte activation-L-selectin shedding. Although we 
did not measure the CD66 antigen, we did measure cell surface 
L-selectin, a molecule thought to present sialylated Lewis (x) 
antigen as a ligand for E-selectin and P-selectin binding (43). 
In experimental studies both in vitro (44) and in animal models 
(45), the neutrophil surface levels of L-selectin correlate with 
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Figure 7. Clinical outcome and leukocyte-platelet interactions: The 
mean platelet fluorescence intensity (number of platelets/leukocyte) is 
presented for the two highest (high and very high intensity) of the 
three ranges where data clustered in all patients studied. The percent 
of leukocytes within each of the two platelet fluorescence intensity 
ranges i  listed under the appropriate histogram before (Pre PTCA) 
and after (Post PTCA) angioplasty for each group (stable [n = 5] or 
chest pain [n = 6]). The mean platelet marker fluorescence intensity of
the monocytes (A)or neutrophils (B) was greater inpatients with chest 
pain events both before and after angioplasty in the high intensity 
range and only after angioplasty in the very high intensity range. The 
percent of monocytes or neutrophils with very high intensity platelet 
fluorescence was higher in patients who had clinical events. 
neutrophil adhesion to endothelium under flow conditions. 
L-selectin levels on neutrophils increased after angioplasty 
and, in our patients with subsequent chest pain events, 
L-selectin levels on both neutrophils and monocytes were 
significantly higher both before and after angioplasty. 
L-selectin is preferentially localized to microvillous processes 
on neutrophils (43), which is distinctly different from CDllb. 
In very early activation states, L-selectin levels detected by 
fluorescein isothiocyanate-conjugated monoclonal ntibodies 
may appear to increase rather than decrease (44). This phe- 
nomenon is thought o be related to steric hindrance of 
fluorescein isothiocyanate conjugated monoclonal antibodies 
when L-selectin density is high; thus, because some L-selectin 
molecules are shed, there is an artificially produced increase in 
the amount of L-selectin detected. 
Leukocyte activation-acute coronary events. Involvement 
of leukocytes in coronary artery thrombosis, inflammation and 
atherogenesis has been demonstrated in numerous experimen- 
tal and clinical studies (3,6-10,46-49). Monocyte xpression 
of CDllb was increased in unstable angina (6) and after 
angioplasty in this pilot study, indicating activation of these 
cells. Potentially deleterious a pects of the monocyte activation 
that occurs during angioplasty include release of cytokines 
(TNFc~, IL-1/3), growth factors (platelet-derived growth factor, 
transforming growth factor-/3, fibroblast growth factor) and 
procoagulants. Cytokines released increase local monocyte 
chemotactic protein-1 synthesis by smooth muscle cells and any 
remaining local endothelial cells, further enhancing monocyte 
recruitment (50). Monocytes from patients with unstable an- 
gina have demonstrated thrombogenic potential with increased 
thrombin formation through expression of tissue factor-like 
activity, part of a lymphocyte-instructed r sponse (7), and high 
levels of inducible tissue factor expression (51). Tissue factor, 
a transmembrane glycoprotein with an extracellular domain, 
serves as a cofactor of Factor VII (52). The resulting complex 
activates factors IX and X, a major source of thrombin 
generation i  vivo. Tissue factor is not expressed by unacti- 
vated cells; however, during simulated extracorporeal circula- 
tion of human whole blood, monocyte tissue factor and CD 1 lb 
expression increased, as did procoagulant activity (53). It 
appears that upregulation of surface CDllb expression is 
associated with enhanced tissue factor expression. The occu- 
pancy of CDllb by surrogate ligands or adhesion enhances the 
tissue factor response when monocytes are further activated 
(54,55). 
Neutrophil or monocyte activation also produces reactive 
oxygen species, chemoattractants (IL-8, complement compo- 
nents), enzymes (hydrolases), arachidonic acid metabolites and 
platelet activating factor. Inevitably during angioplasty, vascu- 
lar mechanical injury occurs (stretch and pressure). In re- 
sponse to this injury, both the neutrophil and monocyte 
activation products intensify local nonocclusive thrombus for- 
mation (56,57), emigration of inflammation cells and stimula- 
tion of resident macrophages and smooth muscle cells in the 
underlying atheromatous plaque. Compared with normal en- 
dothelium, human atheroma obtained uring carotid endarter- 
ectomy, contained many more cells (foam cells, monocytes and 
mesenchymal-appearing intimal cells) synthesizing tissue fac- 
tor (49). In human atheroma obtained during directional 
atherectomy of coronary arteries, tissue factor is detected 
more often in specimens removed from patients with unstable 
angina than in specimens removed from patients with stable 
syndromes (58), suggesting that tissue factor is associated with 
an "active process." 
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Leukocyte.platelet interactions. Certainly, platelets and lo- 
cally derived thrombin have been associated with acute coro- 
nary syndromes, restenosis and nonocclusive thrombus forma- 
tion during angioplasty. These two factors enhance adhesion 
molecule xpression, activate monocytes and neutrophils and 
promote formation of a fibrin meshwork on the exposed 
subendothelial extracellular matrix. As the thrombus propa- 
gates, the meshwork provides a scaffolding for further cellular 
(platelets, neutrophils, monocytes) adherence, aggregation 
and interaction. Unless thrombotic occlusion occurs, elements 
in the blood perfusing the affected artery may be activated, 
interact and continue to circulate. Circulating monocytes and 
neutrophils with bound platelets increase during cardiopulmo- 
nary bypass (29,30). In vitro, thrombin-activated platelets bind 
to leukocytes through a specific epitope on P-selectin, and the 
kinetics of platelet adhesion indicate that monocytes are 
favored (25). In vitro, a much higher percent of monocytes 
bound platelets, and the platelet fluorescence intensity was 
also higher on monocytes than on neutrophils. These findings 
are similar to our in vivo comparisons before and after 
angioplasty. 
The role of monocyte activation and the platelet-leukocyte 
complex in vivo is not certain and has not previously been 
described uring angioplasty. The complexes may modulate 
the proinflammatory and prothrombotic effects of neutrophils 
and monocytes. In this case, our finding that chest pain events 
were associated with a higher percent of monocytes and 
neutrophils with adherent platelets and a greater number of 
platelets/leukocyte, both before and after coronary angio- 
plasty, is supportive of this hypothesis. These clinical events 
occurred despite standard aspirin and heparin therapy, a 
finding that is disappointing but not unexpected (59). 
Limitations of study. The most serious limitation of this 
pilot study is the small number of patients tudied. Analysis of 
the ability to detect a difference for the increase in CDIlb 
expression on monocytes and neutrophils from the three 
sampling sites showed that the most consistent trends were 
associated with lowest p values and best or highest powers. 
Small sample size might account for inability to detect a 
difference for neutrophils in the coronary artery or coronary 
sinus and monocytes in the coronary sinus. The second issue 
involves the technical aspects of flow cytometric analysis. 
Variations occur, and comparing absolute fluorescence inten- 
sities, as we have done, is problematic. However, this study was 
carried out over a very short period of time. The antibodies 
that bind to leukocytes were from a single lot that was carefully 
titered. There was little change in the absolute fluorescence 
intensity of CDllb expression routinely used for clinical 
determinations in the control subjects during this time. 
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